March Madness is finally coming to its conclusion, as the University of Florida and the University of Houston face off in the ...
H.C. Wainwright lowered the firm’s price target on Bicara Therapeutics (BCAX) to $44 from $45 and keeps a Buy rating on the shares following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback